Ezetimibe Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg
Reference Brands: Zetia(US), Ezetrol(EU)
Category:
Heart Disorder
Ezetimibe inhibits intestinal absorption of dietary and biliary cholesterol by blocking the NPC1L1 transporter. It significantly lowers LDL cholesterol, supports cardiovascular health, and reduces atherosclerosis risk. Benefits include effective cholesterol management, often combined with statins for enhanced lipid lowering and improved long-term heart health outcomes.
Ezetimibe tablet is available in Tablet
and strengths such as 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ezetimibe tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ezetimibe tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ezetimibe tablets, marketed as Zetia in the US and Ezetrol in the EU, are approved for lowering LDL cholesterol by inhibiting intestinal absorption. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality information, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability, enabling effective lipid management and cardiovascular risk reduction worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing